枯草杆菌中性蛋白酶基因在大肠杆菌中的表达

蛋白酶是枯草杆菌(Bacillus subtilis)产生的具有重要工业价值的水解酶。对蛋白酶基因的分离与高效率表达一直是基因工程研究领域的重要内容之一^[1-4]。蛋白酶基因的筛选可采用不同的方法,如“免疫法”、“DNA 杂交法”、“遗传互补法”等。大肠杆菌(Escherichia coli)是基因工程中最常用的宿主菌, 若能以E．Coli作为筛选蛋白酶基因的宿主苗,那么使用E．Coli的常规载体,便可直接获得完整的蛋白 酶基因。枯草杆菌的蛋白酶基因能否在大肠杆菌中表达．则是实现这一目标的关键。Koide等人^[5]报道过枯草杆菌的胞内丝氨酸蛋白酶基因在大肠杆菌中的表达。转化细胞在含有脱脂牛奶的平板上可产生十分微弱的水解圈。Ikeraara等人^[6]将Subtilisin E(枯草杆菌蛋白酶E)插人大肠杆菌的表达载体,具有活性的Subtilisin E便可分泌到大肠杆菌的细胞周质中。吴汝平撰文指出^[7]。克隆的枯草杆菌蛋白酶基因不能在大肠杆菌中表达。是因为大肠杆菌不能转录枯草杆菌的促使生长调节基因。Wang等人^[8]则认为,在大肠杆菌中观察不到野生型的中性蛋白酶基因E(nprE)的表达。是因为nprE的表达产物对大肠杆菌有致死作用．除去该基因上的核糖体结合位点,nprE便能在大肠杆菌中低水平表达,并能将表达产 物分泌至胞外。由上可知．枯草杆菌的蛋白酶基因能否在大肠杆菌中表达以及表达的位置仍然是一个众说纷纭的问题,这一问题也正是能否用大肠杆菌作为宿主菌筛选蛋白酶基因的关键。     

大肠杆菌外膜蛋白酶T及其突变体的表达、复性及生物活性分析

外膜蛋白酶T(Outer-membrane protease T,OmpT)是定位于大肠杆菌外膜,具有高度底物特异性的蛋白水解酶。本文旨在建立克隆表达膜蛋白OmpT和体外复性的方法,考察其蛋白酶活性。首先以大肠杆菌基因组DNA为模板,PCR扩增ompT基因,连接至pET28a(pET-ompT),引入点突变Asp85Ala,构建表达质粒pET-ompT85。然后将两种重组质粒转化入BL21(DE3),均以包涵体形式大量表达。纯化后的蛋白经稀释法复性,并加入粗制脂多糖(Lipopolysaccharide,LPS)恢复蛋白酶活性。通过SDS-PAGE、鱼精蛋白水解试验及生长曲线观察表明,重组蛋白OmpT在体外能水解抗菌肽鱼精蛋白和兔肌肉肌酸激酶,而OmpT突变体则无上述功能。上述结果表明本文获得了具有蛋白水解酶功能的重组蛋白OmpT,该蛋白在体外可保护大肠杆菌抵抗鱼精蛋白的杀菌作用。     

枯草芽孢杆菌中性蛋白酶基因的克隆与表达

本研究对枯草芽孢杆菌中性蛋白酶的基因进行克隆,并在大肠杆菌中诱导表达。从枯草芽孢杆菌基因组克隆到编码中性蛋白酶的全长基因,构建大肠杆菌原核表达载体pET30b,转化大肠杆菌BL21得到重组工程菌。通过菌落PCR和酶切筛选验证重组体。在25℃,110 r/min条件下,用IPTG诱导重组蛋白表达。表达蛋白用SDS-PAGE验证,并对酶活力进行测定。测序结果表明克隆序列与NCBI上的登录的序列同源性高达99%。SDS-PAGE结果表明诱导出的蛋白相对分子质量56.6 kD,酶活力达到39 U/mL。证明成功克隆得到枯草芽孢杆菌中性蛋白酶基因,并在大肠杆菌中得到高效表达。     

日本脑炎病毒NS3蛋白酶活性检测及抑制剂高通量筛选方法的建立

日本脑炎病毒(Japanese encephalitis virus,JEV)是单股正链RNA病毒,全基因组仅含有一个开放阅读框,编码一条多聚蛋白前体,病毒编码的NS3蛋白酶在JEV多聚蛋白加工过程中起着重要作用,是重要的药物靶标。通过PCR扩增了NS2BH-NS3蛋白酶的编码区,构建了原核表达质粒并转化到大肠杆菌BL21(DE3),经IPTG诱导得到可溶性的NS3蛋白酶,用镍亲和层析方法进行了纯化。建立了基于荧光共振能量转移的NS3蛋白酶活性检测方法,并确定了最佳的反应条件,对113个化合物进行了筛选,发现其中两个化合物对JEV NS3蛋白酶具有一定的抑制活性。本研究为JEV NS3蛋白酶的活性研究及抑制剂筛选提供了一种操作方便、成本低廉的方法。     

Eglin C与2709碱性蛋白酶相互作用分析及亲和纯化方法

Eglin C是来自水蛭中的一种小型热稳定蛋白质,属于马铃薯胰凝乳蛋白酶抑制剂家族,可以抑制弹性蛋白酶、枯草杆菌蛋白酶、组织蛋白酶、α-lytic蛋白酶以及胰凝乳蛋白酶等.然而,利用eglin C纯化蛋白酶,尚未见研究报道.本文将化学合成的编码eglin C及其突变体的基因序列,克隆到原核表达载体pQE30,在大肠杆菌...     

基质金属蛋白酶抑制剂-4在大肠杆菌中的克隆与表达

基质金属蛋白酶抑制剂4(tissueinhibitorofmetalloproteinase4,TIMP4)为心脏特异性表达,在心脏代谢和肿瘤转移、侵袭过程中具有重要作用。为进一步研究其功能和作用机理,以PCR方法扩增人基质金属蛋白酶抑制剂4不含信号肽的表达序列,测序鉴定正确后,构建原核重组表达质粒pMALc2TIMP4,转化大肠杆菌,IPTG诱导阳性克隆,大量表达重组蛋白。细菌经超声破碎后,其上清中的重组蛋白经SDSPAGE初步鉴定分子量大小与理论值一致,为以后基质金属蛋白酶抑制剂4的研究创造了条件 。     

水稻巯基蛋白酶抑制剂cDNA在大肠杆菌中的表达

根据从水稻未成熟种子cDNA文库中筛选出的水稻巯基蛋白酶抑制剂(Oryzacys-tatin)cDNA序列,利用聚合酶链反应(PCR)技术扩增出Oryzacystatin编码区,插入到温度敏感型大肠杆菌表达载体的PtPL启动子下游．该质粒带有温度敏感型阻遏子的编码基因cIts857。转化大肠杆菌DH5a后。通过升温诱导,Oryzacystatin在大肠杆菌中获得高教表达,SDS—PAGE表明分子量约为12kDa。与预期结果一致,表达量占细菌可溶性蛋白总量的10％以上,对巯基蛋白酶的抑制活性检测表明,可溶性蛋白组分对木瓜蛋白酶有明显的抑制活力。     

大肠杆菌全局调控蛋白CsrA中抑制十字花科黑腐病菌胞外蛋白酶活性所必需的氨基酸残基的鉴定

CsrA/RsmA蛋白家族是细菌中一类重要的转录后全局调控因子,它们调控细菌的碳代谢、次生代谢、运动、生物被膜形成以及致病等过程。CsrA/RsmA蛋白家族通常由60~72个氨基酸基组成,其中第1至第52位氨基酸高度保守,而第53位以后的氨基酸则高度可变。目前人们认为其氨基酸高度保守性是不同种属细菌CsrA/RsmA功能和作用机理相似的基础,但是其高度可变区与不同种属CsrA/RsmA蛋白功能差异的关系尚不清楚。我们之前的研究显示,大肠杆菌(Escherichia coli)的CsrA(CsrAE.coli)蛋白的高度可变区(第53至第61位氨基酸残基)具有强烈的抑制十字花科黒腐病菌(Xanthomonas campestris pathovar campestris,简称Xcc)胞外蛋白酶活性的能力。本研究中,我们采用丙氨酸置换方法,确定了CsrAE. coli可变区中抑制Xcc胞外蛋白酶活性必需的氨基酸残基。结果显示,CsrAE. coli蛋白的第54位赖氨酸(K54)、第60位丝氨酸(S60)和第61位酪氨酸(Y61)置换成丙氨酸后,CsrAE. coli蛋白丧失了抑制Xcc胞外蛋白酶活性的能力;而其它位点的丙氨酸置换不影响其抑制Xcc胞外蛋白酶活性的能力。这个结果证明K54、S60和Y61是CsrAE. coli抑制Xcc胞外蛋白酶活性所必需的,为揭示大肠杆菌的CsrA E.coli蛋白抑制Xcc胞外蛋白酶活性的分子机理奠定基础。     

优化大肠杆菌表达外源蛋白的研究进展

大肠杆菌表达系统是目前表达外源蛋白的首选,利用该表达系统表达重组蛋白有许多优越性,但表达的外源蛋白容易被宿主蛋白酶攻击或未能正确折叠形成包涵体,其表达受到了限制。综述了国内外利用大肠杆菌表达外源蛋白过程中采用的一些优化策略,主要包括表达稀有密码子、应用融合标签,改变表达菌株、降低包涵体形成、单一蛋白技术、自诱导、流加培养以及高密度细胞培养等,以期探索外源蛋白表达的最优策略。     

圣路易斯脑炎病毒NS2B-NS3蛋白酶的原核表达及其抑制剂的筛选

【目的】圣路易斯脑炎病毒(St. Louis encephalitis virus,SLEV)属于黄病毒科,是一种单股正链RNA病毒。黄病毒编码的非结构蛋白NS3在病毒复制以及多聚蛋白加工过程中起着重要作用,NS2B是其发挥作用的重要辅助因子。因此,NS2B-NS3蛋白酶复合物是抗病毒药物的重要靶标。本研究旨在构建SLEV NS2B-NS3蛋白酶的原核表达系统并建立其抑制剂的高通量筛选方法,从而发现其小分子抑制剂。【方法】通过PCR扩增SLEVNS2B-NS3蛋白的编码区,构建原核表达质粒;在大肠杆菌BL21(DE3)中,经异丙基硫代半乳糖苷(Isopropyl β-D-thiogalactoside)诱导得到可溶性的NS2B-NS3蛋白,并用镍亲和层析方法进行纯化;基于荧光共振能量转移(Fluorescence resonance energy transfer)技术检测NS2B-NS3蛋白酶活性,建立其抑制剂的高通量筛选平台。【结果】SLEV NS2B-NS3蛋白酶纯化程度高达95%以上,基于酶活测定的抑制剂筛选平台准确可行。对700多个上市药物进行筛选后,发现原花青素对SLEVNS2B-NS3蛋白酶具有明显的抑制活性。【结论】本研究为SLEVNS2B-NS3蛋白酶抑制剂提供了一种操作方便、高通量的筛选方法,并首次发现了原花青素具有抑制SLEV NS2B-NS3蛋白酶活性的功能,可以作为治疗SLEV感染的潜在靶向药物。     

Target genes for virulence assessment of Escherichia coli isolates from water, food and the environment

The widespread species Escherichia coli includes a broad variety of different types, ranging from highly pathogenic strains causing worldwide outbreaks of severe disease to avirulent isolates which are part of the normal intestinal flora or which are well characterized and safe laboratory strains. The pathogenicity of a given E. coli strain is mainly determined by specific virulence factors which include adhesins, invasins, toxins and capsule. They are often organized in large genetic blocks either on the chromosome ('pathogenicity islands'), on large plasmids or on phages and can be transmitted horizontally between strains. In this review we summarize the current knowledge of the virulence attributes which determine the pathogenic potential of E. coli strains and the methodology available to assess the virulence of E. coli isolates. We also focus on a recently developed procedure based on a broad-range detection system for E. coli-specific virulence genes that makes it possible to determine the potential pathogenicity and its nature in E. coli strains from various sources. This makes it possible to determine the pathotype of E. coli strains in medical diagnostics, to assess the virulence and health risks of E. coli contaminating water, food and the environment and to study potential reservoirs of virulence genes which might contribute to the emergence of new forms of pathogenic E. coli.     

大肠杆菌异源合成三萜化合物研究进展和前景分析

三萜化合物具有可观的药用价值和经济价值,但是目前的生产过程复杂、产量低,利用微生物异源合成三萜化合物已成为当前研究趋势,大肠杆菌作为常用萜类合成底盘细胞具有异源合成三萜化合物及其前体的天然优势和研究前景。对三萜化合物微生物异源合成研究进展进行了综述,从三萜化合物合成代谢途径、关键酶的特点及大肠杆菌三萜表达模块和底盘细胞适配三个方面对该途径进行了阐述和分析,针对实现大肠杆菌高效合成三萜类化合物所需要解决的基础问题进行讨论,为扩展大肠杆菌作为三萜化合物合成底盘细胞提供建议和前景分析。     

Citrate Mannitol Agar Medium for Separating Escherichia coli Paracolons from Shigella

A culture medium is described which not only differentiates Shigella from Escherichia coli but also serves as the basis for an extremely simple test which specifically identifies E. coli. A test that will identify an organism as E. coli is more useful than one that merely groups this species with other non-Shigella organisms. The theoretical basis for specificity of the test for E. coli and other uses for the medium are discussed.     

Escherichia coli bind to urinary bladder epithelium through nonspecific sialic acid mediated adherence

The first step in the bacterial colonization and infection of uropathogenic Escherichia coli is adherence to uroepithelium. Over 80% of all urinary tract infections are caused by E. coli. Uropathogenic E. coli express several adherence factors including type 1 and P fimbriae, which mediate attachment to the uroepithelium through specific binding to different glycoconjugate receptors. We showed that P and type 1 fimbriae are not the sole adhesins on uropathogenic E. coli and sialic acid also mediates nonspecific bacterial adherence of uropathogenic E. coli and urinary bladder epithelium.     

Genes for ribitol and D-arabitol catabolism in Escherichia coli: their loci in C strains and absence in K-12 and B strains.

Escherichia coli C strains can grow at the expense of the two natural pentitols ribitol and D-arabitol, sugar alcohols previously thought not to be utilized by E. coli. E. coli strains K-12 and B cannot utilize either compound. The genetic loci responsible for pentitol catabolism in E. coli C, designated rtl and atl, are separate and closely linked. Each lies between metG and his and is highly co-transducible with metG and with a P2 prophage attachment site. rtl and atl readily can be transduced into E. coli K-12 or B strains, in which they integrate at, or very near, their E. coli C location. Transduction also can be used to insert rtl and atl into certain E. coli K-12 F' plasmids. No recombination between E. coli C strains and either K-12 or B strains occurs within the rtl-atl genetic region after interstrain conjugations or transductions. No cryptic rtl or atl genes in K-12 or B strains can be detected by complementation, recombination, or mutagenesis. These results are consistent with the view that the rtl-atl portion of the E. coli C chromosome has no counterpart in E. coli K-12 or B and may have been obtained from an extrageneric source. Detailed biochemical and genetic comparisons of penitol utilization in E. coli and Klebsiella aerogenes are in progress. The ability to catabolize xylitol is conferred upon E. coli C strains by a mutation at or adjacent to the rtl locus, whereas in E. coli K-12 or B strains harboring rtl an additional mutation at a separate locus is required for xylitol utilization.     

Thioredoxin reductase-mediated hydrogen transfer from Escherichia coli thioredoxin-(SH)2 to phage T4 thioredoxin-S2.

Thioredoxin from Escherichia coli B and phage T4-infected E. coli B are small hydrogen carrier proteins which in their reduced forms are specific hydrogen donors to E. coli and T4-induced ribonucleotide reductase, respectively. The oxidation-reduction active group of both thioredoxins consists of a single cystine residue which is reduced to sulfhydryl form by NADPH in the presence of E. coli thioredoxin reductase. Reduction of T4 thioredoxin-S2 to thioredoxin-(SH)2 led to a 3-fold increase in the quantum yield of tyrosine fluorescence. By using the spectrofluorimetric properties of T4 thioredoxin and E. coli thioredoxin as markers for their oxidized and reduced forms we have shown that E. coli thioredoxin reductase catalyzed the reaction: (see article) whose equilibrium constant favors formation of E. coli thioredoxin-S2 and T4 thioredoxin-(SH)2. This finding suggests that in the T4-infected cell most of the deoxyribonucleotides required for the viral DNA might be synthesized by the T4-induced ribonucleotide reductase while the host ribonucleotide reductase is inactive due to the shortage of reduced E. coli thioredoxin.